Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America



Insiderslab.com is has released insider trading report for US market investors to track the performance of company insiders, which can help the portfolios. Today’s report will cover the following stocks: Facebook (NASDAQ:FB), Zynga (NASDAQ:ZNGA), Arena Pharmaceuticals (NASDAQ:ARNA), Lululemon Athletica (NASDAQ:LULU), Weatherford International (NYSE:WFT), and Bank of America (NYSE:BAC).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
Facebook Inc (NASDAQ:FB)): By the end of last trading session, the shares of Facebook (NASDAQ:FB) lost US$0.29 (or 0.64%) to US$44.75 with 68.05 million shares exchanged hands, compared to daily average volume of 65.38 million. Insiderslab.com found company VP Marketing & Bus. Part., David B. Fischer, sold his shares at the price of US$43.38 on September 11. One day before, the company Chief Operating Officer, Sheryl Sandberg, sold her shares at the price of US$43.69, which was part of her US$123.10 million selling within last three months. Investors may want to find out how Facebook insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for FB here.
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/FB/Facebook.pdf
 
Zynga Inc (NASDAQ:ZNGA): By the end of last trading session, Zynga (NASDAQ:ZNGA) shares earned 0.67% to US$3.02 with about 14.74 million shares exchanged hands for the session, compared to its average volume of 15.65 million shares. Insiderslab.com found company Directors, Stanley J. Meresman and Jeffrey Katzenberg, sold their shares at the price of US$2.86 on September 3. Investors may want to find out how Zynga insiders like CEOs, CFOs and Directors are thinking about the future of the company.
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/ZNGA/Zynga.pdf
 
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): By the end of last trading session, Arena Pharmaceuticals (NASDAQ:ARNA) dropped 2.57% to US$5.87 with about 9.45 million shares exchanged hands for the session, compared to its average volume of 4.61 million shares. Insiderslab.com found company EVP & Chief Scientific Officer, Dominic P. Behan, sold his shares at the price of US$6.31 for about US$1.26 million on September 10. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Arena are starting to sell more company shares. See insider trade report for ARNA here.
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/ARNA/Arena.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
Lululemon Athletica inc. (NASDAQ:LULU):
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/LULU/LululemonAthletica.pdf
 
Weatherford International Ltd (NYSE:WFT):
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/WFT/Weatherford.pdf
 
Bank of America Corp (NYSE:BAC):
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/BAC/BankofAmerica.pdf
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
Source:
www.insiderslab.com
www.insiderslab.com

Reported on Sep 13, 2013

 
More Insider News ...

Today's Notable Trades


LATTICE SEMICONDUCTOR CORP (LSCC)
Director: KRISHNAMURTHY BALAJI

Acquired 10,000 Common Stock (Non-Derivative security at $4.530) on Aug 29, 2014. Direct holding 68,306 shares/units after transaction. Holdings increased 17.15%.
Filing date: Sep 2, 2014. Record updated at 22:40:27.
 
RELIABILITY INC (RLBY)
10% shareholder: Eberwein Jeffrey E.

Sold 6,786,588 Common Stock (Non-Derivative security at $0.125) on Aug 29, 2014. Indirect holding 0 shares/units after transaction. Holdings decreased -100.00%.
Filing date: Sep 2, 2014. Record updated at 22:35:14.
 
SYNAPTICS INC (SYNA)
Senior Officer (SVP of Sales): Deutsch Scott

Acquired 1,273 Common Stock (Non-Derivative security at $35.760) on Aug 28, 2014. Direct holding 11,635 shares/units after transaction. Holdings increased 12.29%.
Filing date: Aug 28, 2014. Record updated at 22:34:07.
 
'mktg, inc.' (CMKG)
Director: FEINSTEIN RICHARD L

Sold 10,000 Common Stock (Non-Derivative security at $2.800) on Aug 27, 2014. Direct holding 0 shares/units after transaction. Holdings decreased -100.00%.
Filing date: Aug 27, 2014. Record updated at 22:33:14.
 
Hillshire Brands Co (HSH)
Director: BROTHERS ELLEN L

Sold 9,883 Common Stock (Non-Derivative security at $63.000) on Aug 28, 2014. Direct holding 0 shares/units after transaction. Holdings decreased -100.00%.
Filing date: Sep 2, 2014. Record updated at 22:28:21.
 
Cytosorbents Corp (CTSO)
Director: Gunton James T.

Sold 214,387 Common Stock (Non-Derivative security at $0.236) on Aug 28, 2014. Indirect holding 1,532,601 shares/units after transaction. Holdings decreased -12.27%.
Filing date: Sep 2, 2014. Record updated at 22:27:45.
 
CONCHO RESOURCES INC (CXO)
Senior Officer (Senior VP & CFO): HOLDERNESS DARIN G

Sold 15,000 Common Stock (Non-Derivative security at $140.000) on Aug 29, 2014. Direct holding 60,450 shares/units after transaction. Holdings decreased -19.88%.
Filing date: Aug 29, 2014. Record updated at 22:26:52.
 
AMBARELLA INC (AMBA)
Senior Officer (Executive Vice President): LeGall Didier

Acquired 10,000 Ordinary Shares (Non-Derivative security at $2.930) on Aug 29, 2014. Direct holding 71,742 shares/units after transaction. Holdings increased 16.20%.
Filing date: Sep 2, 2014. Record updated at 22:22:44.
 
TERADYNE, INC (TER)
Director: BRADLEY MICHAEL A

Acquired 39,024 Common Stock (Non-Derivative security at $9.340) on Aug 29, 2014. Direct holding 192,373 shares/units after transaction. Holdings increased 25.45%.
Filing date: Sep 2, 2014. Record updated at 22:21:51.
 
Seagate Technology plc (STX)
Senior Officer (EVP,General Counsel, CAO): MASSARONI KENNETH M

Acquired 7,500 Ordinary Shares (Non-Derivative security at $13.730) on Aug 29, 2014. Direct holding 81,487 shares/units after transaction. Holdings increased 10.14%.
Filing date: Sep 2, 2014. Record updated at 22:16:32.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.